Amir Steinberg is an Oncology physician affiliated with Westchester Medical Center. OpenAlex indexes 197 publications with 1,435 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10 E 102nd St
New York, NY 100296030
Telephone
212-241-6756Provider last certified this registry record 7 Jul 2021.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Janssen Scientific Affairs, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
35.5%Thalidomide Analog20.6%Revlimid79%Lenalidomide21%Part D<11 patientsKinase inhibitor14.9%Iclusig38%Sprycel33%Imbruvica29%Part D<11 patientsDermatology
25.2%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor25.2%Acyclovir100%Part D≥16 patientsMetabolism & gastrointestinal
11.7%Corticosteroid7.8%Prednisone100%Part D<11 patientsProton pump inhibitor3.9%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Using bispecific antibodies in a patient with peritoneal dialysis for relapsed multiple myeloma
Journal of Oncology Pharmacy Practice
2025 - Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation
Biology of Blood and Marrow Transplantation
2024 - Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis
Biology of Blood and Marrow Transplantation
2023 - New-onset persistent hyperglycemia with initiation of brentuximab treatment
Journal of Oncology Pharmacy Practice
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Ankur Kalra, MD
Westchester Medical Center
Stuart Berezin, MD
Westchester Medical Center
Jason Jacobson, MD
Westchester Medical Center
Seth Lessner, MD
Westchester Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”